About Supha Pharmachem Limited
Data last updated: 14 July 2026
Supha Pharmachem Limited is a public limited company based in Mumbai, Maharashtra, India. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 19 February 1988, the company has been in operation for over 38 years.
Registered with ROC Mumbai under CIN L24100MH1988PLC343805. Listed on BSE: 539561.
Capital: an authorised share capital of ₹110 Cr and a paid-up capital of ₹88.2 Cr. Formerly known as Roxy Exports Limited and Supha Pharmachem Limited. It is led by directors including Vignesh Laxman Gawde and Rambhajan Vishwakarma.
Last AGM: 24 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.
As per BSE-filed consolidated financials for FY 2025, the company reported a revenue of ₹405.25 Cr. The net worth stands at ₹43.89 Cr. Total assets are valued at ₹1,720.35 Cr.
The company has a workforce of approximately 6 employees as per the latest available data.
The company is associated with 2 brands - Remedium Lifecare, Roxy Exports. As per MCA filings, the company has satisfied charges of ₹3.26 Cr on record.
The company is undergoing Corporate Insolvency Resolution Process (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency professional, and the company may not be able to independently enter into new commitments. The last known website on record is remediumlifecare.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressOffice No.9 K Raheja Prime Marol Industrial Estate, Behind Ravi Vihar Hotel Sagbaug Road Marol Andheri East, Mumbai, Maharashtra, India – 400059
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Supha Pharmachem Limited
Supha Pharmachem Limited has undergone 2 name changes throughout its history. The company was previously known as Roxy Exports Limited, and Supha Pharmachem Limited. The current legal name is Supha Pharmachem Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Supha Pharmachem Limited | Current |
| Roxy Exports Limited | Previous |
CIN History of Supha Pharmachem Limited
Supha Pharmachem Limited has 4 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L24100MH1988PLC343805, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24100MH1988PLC343805 | Current |
| L51909PB1988PLC008009 | Previous |
| L29100MH1988PLC343805 | Previous |
| U51909PB1988PLC008009 | Previous |
| L29100PB1988PLC008009 | Previous |
Associated Brands with Supha Pharmachem Limited
Supha Pharmachem Limited operates two associated brands: Remedium Lifecare and Roxy Exports. These brands represent Supha Pharmachem Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Trading of pharmaceutical APIs and intermediates is conducted in domestic and international markets. | remediumlifecare.com | |
| Solutions for generating water from atmospheric air are provided. | roxyexports.in |
Competitors & Alternatives of Supha Pharmachem Limited
Brands and companies operating in the same space as Supha Pharmachem Limited include Uravu Labs, Kara Water, SunToWater Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Uravu Labs
|
Developer of air-to-water generating systems | Bengaluru, India, India | 2019 |
Kara Water
|
Manufacturer of air-to-water devices producing mineral-rich alkaline water and coffee | New York, United States, United States | 2017 |
SunToWater Technologies
|
Water is generated from air via solar-powered dehumidification systems. | Palo Alto, United States, United States | 2012 |
Akvo
|
Water is generated from air using innovative atmospheric technology. | Kolkata, India, India | 2016 |
Majik Water
|
Water is harvested from air using solar-powered intake fans. | Nairobi, Kenya, Kenya | 2017 |
Drinkable Air Technologies
|
Provider of products that produce water from air | Fort Lauderdale, United States, United States | 2010 |
Atmospheric Water Solutions
|
Atmospheric water generators are supplied for residential and commercial applications. | Cooper City, United States, United States | 2011 |
ThinAir Water
|
Delivers innovative solutions using water-from-air technology. | London, United Kingdom, United Kingdom | 2016 |
AquaPoro
|
Creates atmospheric water generators for residential, commercial, and municipal use. | Amman, Jordan, Jordan | 2022 |
Business Activity of Supha Pharmachem Limited
Supha Pharmachem Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details for Supha Pharmachem Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Supha Pharmachem Limited
Supha Pharmachem Limited is audited by TAORI SANDEEP & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| TAORI SANDEEP & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Supha Pharmachem Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Supha Pharmachem Limited
Supha Pharmachem Limited is currently managed by 6 directors, with 25 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vignesh Laxman Gawde | Whole-Time Director | 31 Oct 2025 | 0 Years 9 Months | As last reported |
| Rambhajan Vishwakarma | Director | 31 Oct 2025 | 0 Years 9 Months | As last reported |
| Vijay Pal Singh Gulya | Director | 30 May 2025 | 1 Years 2 Months | As last reported |
|
Bikram Kumar Mund
Also directs:
True Value Propmart Private Limited, Carvan Builders Private Limited, Indiacraft Overseas Private Limited and 1 more
|
Director | 30 May 2025 | 1 Years 2 Months | As last reported |
| Shamim Adil Michal | Director | 22 Jan 2025 | 1 Years 6 Months | As last reported |
|
Adarsh Deepak Munjal
Also directs:
Risevertise Media Llp
|
Director | 05 Sep 2023 | 2 Years 11 Months | As last reported |
Financials of Supha Pharmachem Limited FY 2025 filings available
Supha Pharmachem Limited reported revenue of ₹405.25 Cr for FY 2025.
| Metrics | FY 2025 |
|---|---|
| Revenue from Operations | ₹405.25 Cr |
| Other Income | ₹10.8 Cr |
| Total Income | ₹416.05 Cr |
| Cost of Materials Consumed | ₹0 |
| Purchases of Stock-in-Trade | ₹534.28 Cr |
| Changes in Inventories | -₹136.15 Cr |
| Employee Benefit Expense | ₹75.6 Lakh |
| Finance Costs | ₹5.29 Cr |
| Depreciation & Amortisation | ₹3.87 Lakh |
| Other Expenses | ₹7.45 Cr |
| Total Expenses | ₹411.67 Cr |
| Profit Before Exceptional Items & Tax | ₹4.38 Cr |
| Exceptional Items | ₹0 |
| Profit Before Tax | ₹4.38 Cr |
| Total Tax Expense | ₹2.25 Cr |
| Net Profit | ₹2.13 Cr |
| attributable to Owners | ₹59.74 Lakh |
| attributable to NCI | ₹0 |
| Other Comprehensive Income | ₹0 |
| Total Comprehensive Income | ₹2.13 Cr |
| EBITDA (computed) | ₹9.71 Cr |
| Basic EPS | ₹0.05 |
| Diluted EPS | ₹0.05 |
| Metrics | FY 2025 |
|---|---|
| Total Assets | ₹1,720.35 Cr |
| Non-current Assets | ₹4.41 Lakh |
| Current Assets | ₹1,720.31 Cr |
| Property, Plant & Equipment | ₹83,000 |
| Inventories | ₹269.38 Cr |
| Trade Receivables | ₹771.62 Cr |
| Cash & Equivalents | ₹28.15 Lakh |
| Equity (Net Worth) | ₹43.89 Cr |
| Equity Share Capital | ₹40.32 Cr |
| Borrowings (Non-current) | ₹0 |
| Borrowings (Current) | ₹1,141.39 Cr |
| Total Debt (computed) | ₹1,141.39 Cr |
| Current Liabilities | ₹1,676.46 Cr |
| Total Liabilities | ₹1,676.46 Cr |
| Metrics | FY 2025 |
|---|---|
| Operating Cash Flow | -₹1,134.81 Cr |
| Investing Cash Flow | ₹12.89 Lakh |
| Financing Cash Flow | ₹1,136.1 Cr |
| Capital Expenditure | ₹0 |
| Free Cash Flow (computed) | -₹1,134.81 Cr |
| Dividends Paid | ₹0 |
| Net Change in Cash | ₹1.43 Cr |
| Metrics | Q2 FY26 | Q1 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from Operations | ₹111.06 Cr | ₹113.37 Cr | ₹264.32 Cr |
| Other Income | ₹3.25 Cr | ₹3.48 Cr | ₹65.93 Lakh |
| Total Income | ₹114.31 Cr | ₹116.84 Cr | ₹264.98 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹98.03 Cr | ₹101.69 Cr | ₹191.01 Cr |
| Changes in Inventories | ₹2.45 Cr | ₹6.14 Cr | ₹71.66 Cr |
| Employee Benefit Expense | ₹19.07 Lakh | ₹19.6 Lakh | ₹9.27 Lakh |
| Finance Costs | ₹18.72 Lakh | -₹36.49 Lakh | ₹1.59 Cr |
| Depreciation & Amortisation | ₹3,000 | ₹1,000 | ₹97,000 |
| Other Expenses | ₹3.02 Cr | ₹3.47 Cr | ₹2.02 Cr |
| Total Expenses | ₹103.88 Cr | ₹111.13 Cr | ₹266.38 Cr |
| Profit Before Exceptional Items & Tax | ₹10.44 Cr | ₹5.71 Cr | -₹1.4 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.44 Cr | ₹5.71 Cr | -₹1.4 Cr |
| Total Tax Expense | ₹1.81 Cr | ₹1.06 Cr | ₹64.56 Lakh |
| Net Profit | ₹8.62 Cr | ₹4.65 Cr | -₹2.05 Cr |
| attributable to Owners | ₹0 | ₹5.01 Cr | ₹59.74 Lakh |
| attributable to NCI | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹8.62 Cr | ₹4.65 Cr | -₹2.05 Cr |
| EBITDA (computed) | ₹10.62 Cr | ₹5.35 Cr | ₹20.26 Lakh |
| Basic EPS | ₹0.10 | ₹0.05 | ₹-0.05 |
| Diluted EPS | ₹0.10 | ₹0.05 | ₹-0.05 |
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹222.5 Cr | ₹4,041.71 Cr | ₹509.84 Cr | ₹504.79 Cr | ₹90.03 Cr | ₹2.89 Cr | ₹15.91 Lakh |
| Other Income | ₹10.8 Cr | ₹21.08 Cr | ₹400 | ₹400 | ₹20,500 | ₹0 | ₹8.8 Lakh |
| Total Income | ₹233.3 Cr | ₹4,062.79 Cr | ₹509.84 Cr | ₹504.79 Cr | ₹90.04 Cr | ₹2.89 Cr | ₹24.71 Lakh |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹498.47 Cr | ₹87.74 Cr | ₹1.67 Cr | ₹4.51 Lakh |
| Purchases of Stock-in-Trade | ₹352.26 Cr | ₹4,127.28 Cr | ₹417.3 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹136.15 Cr | -₹125.91 Cr | ₹76.55 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹75.6 Lakh | ₹84.27 Lakh | ₹98.33 Lakh | ₹53.32 Lakh | ₹18.8 Lakh | ₹18.38 Lakh | ₹4.06 Lakh |
| Finance Costs | ₹5.29 Cr | ₹3.87 Cr | -₹7.55 Lakh | ₹10.7 Lakh | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹3.87 Lakh | ₹5.67 Lakh | ₹15.08 Lakh | ₹7.38 Lakh | ₹6.01 Lakh | ₹1.32 Lakh | ₹0 |
| Other Expenses | ₹7.44 Cr | ₹6.19 Cr | ₹7.53 Cr | ₹4.08 Cr | ₹1.4 Cr | ₹64.42 Lakh | ₹14.22 Lakh |
| Total Expenses | ₹229.64 Cr | ₹4,012.33 Cr | ₹502.44 Cr | ₹503.27 Cr | ₹89.38 Cr | ₹2.52 Cr | ₹22.79 Lakh |
| Profit Before Exceptional Items & Tax | ₹3.66 Cr | ₹50.45 Cr | ₹7.4 Cr | ₹1.53 Cr | ₹65.29 Lakh | ₹37.5 Lakh | ₹1.92 Lakh |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹3.66 Cr | ₹50.45 Cr | ₹7.4 Cr | ₹1.53 Cr | ₹65.29 Lakh | ₹37.5 Lakh | ₹1.92 Lakh |
| Total Tax Expense | ₹2.13 Cr | ₹17.72 Cr | ₹1.97 Cr | ₹44.73 Lakh | ₹17.24 Lakh | ₹9.8 Lakh | ₹1.12 Lakh |
| Net Profit | ₹1.53 Cr | ₹32.73 Cr | ₹5.43 Cr | ₹1.08 Cr | ₹48.05 Lakh | ₹27.7 Lakh | ₹80,000 |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹1.53 Cr | ₹32.73 Cr | ₹5.43 Cr | ₹1.08 Cr | ₹48.05 Lakh | ₹27.7 Lakh | ₹80,000 |
| EBITDA (computed) | ₹8.99 Cr | ₹54.38 Cr | ₹7.47 Cr | ₹1.71 Cr | ₹71.29 Lakh | ₹38.81 Lakh | ₹1.92 Lakh |
| Basic EPS | ₹0.04 | ₹3.25 | ₹15.07 | ₹2.99 | ₹0.72 | ₹0.77 | ₹0.02 |
| Diluted EPS | ₹0.04 | ₹3.25 | ₹15.07 | ₹2.99 | ₹0.72 | ₹0.77 | ₹0.02 |
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,539.65 Cr | ₹1,947.92 Cr | ₹1,154.22 Cr | ₹223.76 Cr | ₹38.53 Cr | ₹4.27 Cr | ₹3.53 Cr |
| Non-current Assets | ₹10.92 Lakh | ₹7.37 Lakh | ₹8.55 Lakh | ₹18.61 Lakh | ₹21.01 Lakh | ₹23.12 Lakh | ₹4,000 |
| Current Assets | ₹1,539.54 Cr | ₹1,947.85 Cr | ₹1,154.14 Cr | ₹223.57 Cr | ₹38.32 Cr | ₹4.04 Cr | ₹3.53 Cr |
| Property, Plant & Equipment | ₹83,000 | ₹4.7 Lakh | ₹7.81 Lakh | ₹8.54 Lakh | ₹7.3 Lakh | ₹5.79 Lakh | ₹0 |
| Inventories | ₹269.38 Cr | ₹133.23 Cr | ₹7.32 Cr | ₹83.87 Cr | ₹3.11 Cr | ₹70.12 Lakh | ₹20.47 Lakh |
| Trade Receivables | ₹590.92 Cr | ₹920.6 Cr | ₹172.37 Cr | ₹64 Cr | ₹23.68 Cr | ₹1.5 Cr | ₹13.7 Lakh |
| Cash & Equivalents | ₹28.15 Lakh | ₹27.07 Lakh | ₹24.36 Lakh | ₹69.8 Lakh | ₹66.31 Lakh | ₹84.05 Lakh | ₹1.07 Cr |
| Equity (Net Worth) | ₹43.3 Cr | ₹42.96 Cr | ₹10.36 Cr | ₹4.94 Cr | ₹3.86 Cr | ₹3.35 Cr | ₹3.08 Cr |
| Equity Share Capital | ₹40.32 Cr | ₹10.08 Cr | ₹3.6 Cr | ₹3.6 Cr | ₹3.6 Cr | ₹3.6 Cr | ₹3.6 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹10.5 Cr | ₹36.43 Lakh | ₹0 |
| Borrowings (Current) | ₹1,141.39 Cr | ₹57.7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹7.6 Lakh |
| Total Debt (computed) | ₹1,141.39 Cr | ₹57.7 Cr | ₹0 | ₹0 | ₹10.5 Cr | ₹36.43 Lakh | ₹7.6 Lakh |
| Current Liabilities | ₹1,496.35 Cr | ₹1,904.97 Cr | ₹1,143.86 Cr | ₹218.82 Cr | ₹24.17 Cr | ₹54.67 Lakh | ₹44.95 Lakh |
| Total Liabilities | ₹1,496.35 Cr | ₹1,904.97 Cr | ₹1,143.86 Cr | ₹218.82 Cr | ₹34.68 Cr | ₹91.47 Lakh | ₹44.95 Lakh |
| Metrics | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Cash Flow | -₹1,078.63 Cr | -₹74.16 Cr | ₹20.5 Cr | ₹11.28 Cr |
| Investing Cash Flow | ₹6.38 Lakh | ₹0 | -₹4.27 Lakh | -₹4.98 Lakh |
| Financing Cash Flow | ₹1,078.4 Cr | ₹53.83 Cr | -₹3.74 Lakh | -₹10.61 Cr |
| Capital Expenditure | ₹0 | ₹0 | ₹0 | ₹4.98 Lakh |
| Free Cash Flow (computed) | -₹1,078.63 Cr | -₹74.16 Cr | ₹20.5 Cr | ₹11.23 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | -₹16.01 Lakh | -₹20.33 Cr | ₹20.42 Cr | ₹62.49 Lakh |
| Metrics | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹8.58 Cr | ₹18.37 Cr | ₹81.57 Cr | ₹38.15 Cr | ₹25.08 Cr | ₹77.7 Cr |
| Other Income | ₹3.25 Cr | ₹3.48 Cr | ₹65.93 Lakh | ₹7.43 Cr | ₹82.23 Lakh | ₹1.89 Cr |
| Total Income | ₹11.83 Cr | ₹21.85 Cr | ₹82.23 Cr | ₹45.58 Cr | ₹25.9 Cr | ₹79.59 Cr |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹5.91 Cr | ₹12.81 Cr | ₹8.98 Cr | ₹77.7 Cr | ₹115.39 Cr | ₹150.18 Cr |
| Changes in Inventories | ₹2.45 Cr | ₹6.14 Cr | ₹71.66 Cr | -₹37.27 Cr | -₹96.44 Cr | -₹74.1 Cr |
| Employee Benefit Expense | ₹19.07 Lakh | ₹19.6 Lakh | ₹9.27 Lakh | ₹20.29 Lakh | ₹23.8 Lakh | ₹22.24 Lakh |
| Finance Costs | ₹18.72 Lakh | -₹36.49 Lakh | ₹1.59 Cr | ₹88.36 Lakh | ₹2.81 Cr | ₹0 |
| Depreciation & Amortisation | ₹3,000 | ₹1,000 | ₹97,000 | ₹96,700 | ₹96,700 | ₹96,700 |
| Other Expenses | ₹3.02 Cr | ₹3.43 Cr | ₹2.01 Cr | ₹2.99 Cr | ₹1.43 Cr | ₹1.01 Cr |
| Total Expenses | ₹11.76 Cr | ₹22.22 Cr | ₹84.35 Cr | ₹44.52 Cr | ₹23.44 Cr | ₹77.32 Cr |
| Profit Before Exceptional Items & Tax | ₹7.38 Lakh | -₹36.51 Lakh | -₹2.12 Cr | ₹1.06 Cr | ₹2.46 Cr | ₹2.27 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹7.38 Lakh | -₹36.51 Lakh | -₹2.12 Cr | ₹1.06 Cr | ₹2.46 Cr | ₹2.27 Cr |
| Total Tax Expense | ₹0 | ₹0 | ₹52.32 Lakh | ₹29.47 Lakh | ₹68.41 Lakh | ₹63.05 Lakh |
| Net Profit | ₹7.38 Lakh | -₹36.51 Lakh | -₹2.64 Cr | ₹76.45 Lakh | ₹1.77 Cr | ₹1.64 Cr |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹7.38 Lakh | -₹36.51 Lakh | -₹2.64 Cr | ₹76.45 Lakh | ₹1.77 Cr | ₹1.64 Cr |
| EBITDA (computed) | ₹26.13 Lakh | -₹72.99 Lakh | -₹51.72 Lakh | ₹1.95 Cr | ₹5.28 Cr | ₹2.28 Cr |
| Basic EPS | ₹0.00 | ₹0.00 | ₹-0.07 | ₹0.02 | ₹0.04 | ₹0.16 |
| Diluted EPS | ₹0.00 | ₹0.00 | ₹-0.07 | ₹0.02 | ₹0.04 | ₹0.16 |
Shareholding Pattern of Supha Pharmachem Limited
As per the shareholding pattern filed with BSE for the quarter ended Dec 2025, promoters hold 1.13%, foreign institutional investors hold 1.70%, retail and other public shareholders hold 97.17% of Supha Pharmachem Limited. The company had 111,269 shareholders on record.
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 1.13% | 1.13% | 1.13% | 1.11% | 1.11% | 1.11% |
| Public | 98.87% | 98.87% | 98.87% | 98.89% | 98.89% | 98.89% |
| Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|
| Promoters | 1.11% | 1.11% | 1.11% |
| Public | 98.89% | 98.89% | 98.89% |
| Promoter change (YoY, %pts) | +0.00 | +0.00 | - |
Charges & Borrowings of Supha Pharmachem Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2012 | Indian Overseas Bank | ₹95 Lakh | Satisfied |
| 07 Jan 2011 | Indian Overseas Bank | ₹1.5 Cr | Satisfied |
| 20 Feb 1996 | Punjab National Bank | ₹6 Lakh | Satisfied |
| 02 Aug 1995 | Punjab National Bank | ₹2.5 Lakh | Satisfied |
| 24 Apr 1995 | Punjab National Bank | ₹15 Lakh | Satisfied |
Total charge records: 14 View all charges
Employees and EPFO Compliance at Supha Pharmachem Limited
Supha Pharmachem Limited has a workforce of 6 employees as of Mar 29, 2024.
Employee and EPFO history for Supha Pharmachem Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Supha Pharmachem Limited
GST registrations and filing compliance for Supha Pharmachem Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Supha Pharmachem Limited
Credit ratings, litigation, and regulatory alerts for Supha Pharmachem Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Supha Pharmachem Limited
MSME payment history for Supha Pharmachem Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Supha Pharmachem Limited
Corporate group structure for Supha Pharmachem Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Supha Pharmachem Limited
MCA filings and documents for Supha Pharmachem Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Supha Pharmachem Limited
Recent News on Supha Pharmachem Limited
Frequently Asked Questions about Supha Pharmachem Limited
Supha Pharmachem Limited is undergoing "Corporate Insolvency Resolution Process" (CIRP) under the Insolvency and Bankruptcy Code, 2016. Management control has been transferred to an insolvency resolution professional. The company may not be able to independently enter into new commitments during this period. This is a high-risk status - verify the resolution status before any engagement.
Supha Pharmachem Limited is a company under insolvency, formerly operating as a public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 19 February 1988 and is registered under CIN L24100MH1988PLC343805. Listed on BSE: 539561. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Supha Pharmachem Limited reported revenue of ₹405.25 Cr for FY 2025 based on consolidated BSE filings.
The current directors of Supha Pharmachem Limited are:
- Vignesh Laxman Gawde - Whole-Time Director
- Rambhajan Vishwakarma - Director
- Vijay Pal Singh Gulya - Director
- Bikram Kumar Mund - Director
- Shamim Adil Michal - Director
- Adarsh Deepak Munjal - Director
The CIN (Corporate Identification Number) of Supha Pharmachem Limited is L24100MH1988PLC343805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Supha Pharmachem Limited is listed on BSE with code 539561.